Skip to main content
Back
CTRE logo

CareTrust REIT, Inc.

Data quality: 100%
CTRE
NYSE Real Estate REIT - Healthcare Facilities
$37.45
▲ $1.35 (3.73%)
Mkt Cap: 7.24B
Day Range
$36.88 $38.29
52-Week Range
$25.82 $41.72
Volume
4,380,923
50D / 200D Avg
$38.74 / $35.07
Prev Close
$36.10

Price History

Financial Trends

Peer Comparison

vs Real Estate sector median (361 peers)

Metric Stock Sector Median
P/E 22.6 11.1
P/B 1.8 0.8
ROE % 9.2 6.1
Net Margin % 67.3 19.9
Rev Growth 5Y % 25.8 7.0
D/E 0.2 0.9

Key Takeaways

Revenue grew 25.82% annually over 5 years — strong growth
Earnings grew 156.27% over the past year
Net margin of 67.26% shows strong profitability
Debt/Equity of 0.22 — conservative balance sheet
Generating 379.04M in free cash flow
PEG of 0.24 suggests growth is underpriced

Growth

Revenue Growth (5Y)
25.82%
Revenue (1Y)108.79%
Earnings (1Y)156.27%
FCF Growth (3Y)62.36%

Quality

Return on Equity
9.23%
ROIC4.87%
Net Margin67.26%
Op. Margin67.17%

Safety

Debt / Equity
0.22
Current Ratio1.54
Interest Coverage7.32

Valuation

P/E Ratio
22.59
P/B Ratio1.79
EV/EBITDA24.79
Dividend Yield0.04%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 108.79% Revenue Growth (3Y) 54.91%
Earnings Growth (1Y) 156.27% Earnings Growth (3Y) 144.24%
Revenue Growth (5Y) 25.82% Earnings Growth (5Y) 45.27%
Profitability
Revenue (TTM) 476.59M Net Income (TTM) 320.54M
ROE 9.23% ROA 6.23%
Gross Margin 59.13% Operating Margin 67.17%
Net Margin 67.26% Free Cash Flow (TTM) 379.04M
ROIC 4.87% FCF Growth (3Y) 62.36%
Safety
Debt / Equity 0.22 Current Ratio 1.54
Interest Coverage 7.32 Dividend Yield 0.04%
Valuation
P/E Ratio 22.59 P/B Ratio 1.79
P/S Ratio 15.19 PEG Ratio 0.24
EV/EBITDA 24.79 Dividend Yield 0.04%
Market Cap 7.24B Enterprise Value 7.94B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 476.59M 228.26M 198.60M 187.51M 190.20M
Net Income 320.54M 125.08M 53.74M -7.51M 71.98M
EPS (Diluted) 1.57 0.80 0.50 0.44 0.50
Gross Profit 281.79M 214.71M 189.01M 178.13M 186.62M
Operating Income 320.14M 124.06M 116.00M 103.81M 104.41M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 5.15B 3.44B 2.08B 1.62B 1.64B
Total Liabilities 1.09B 507.63M 666.12M 771.41M 725.09M
Shareholders' Equity 4.04B 2.91B 1.42B 849.37M 915.76M
Total Debt 894.22M 396.93M 595.60M 719.50M 673.40M
Cash & Equivalents 198.04M 213.82M 294.45M 13.18M 19.90M
Current Assets 300.60M 368.26M 309.85M 25.89M 27.15M
Current Liabilities 195.25M 110.71M 70.52M 176.91M 131.69M

Strategy Scores

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
#617 of 1024
40
#13 of 326
81

Recent Activity

Entered Cash Flow Compounder
Mar 24, 2026
Entered Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026